Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Allergology International : Official Journal of the Japanese Society of Allergology|March 27, 2007
Flavonoids and related compounds as anti-allergic substancesMari Kawai, Toru Hirano, Shinji Higa, et al.
Lupus|February 26, 2025
Systemic lupus erythematosus with hypothermia and Wallenberg's syndrome as signs of brainstem encephalitis: A grand rounds caseReo Shiratani, Takayuki Shibahara, Mikio Shiba, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
IL-18 gene polymorphisms affect IL-18 production capability by monocytesJunsuke Arimitsu, Toru Hirano, Shinji Higa, et al.
Biochemical and Biophysical Research Communications|December 14, 2005
Luteolin, a flavonoid, inhibits AP-1 activation by basophilsToru Hirano, Shinji Higa, Junsuke Arimitsu, et al.
Modern Rheumatology|June 7, 2012
Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumabMie Fusama, Hideko Nakahara, Yoshimasa Hamano, et al.
International Archives of Allergy and Immunology|March 20, 2009
Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trialMari Kawai, Toru Hirano, Junsuke Arimitsu, et al.
Annals of the Rheumatic Diseases|November 9, 2019
Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese populationToshihiro Kishikawa, Yuichi Maeda, Takuro Nii, et al.
Modern Rheumatology|April 7, 2022
Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis: Post-hoc subgroup analysis of the ORIGAMI studyTakanori Azuma, Kenta Misaki, Makio Kusaoi, et al.
Nature Communications|June 17, 2025
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosisHiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Effect of Recent Antirheumatic Drug on Features of Rheumatoid Arthritis-Associated Lymphoproliferative DisordersYoshihiko Hoshida, Atsuko Tsujii, Shiro Ohshima, et al.
Pageof 2